Don't think update will happen. I'm one of the investors assuming that Brastianos will cite disordered PI3K as a common target in primary and secondary cancers.
There's also the possibility it'll be mentioned with regards to breast cancer brain metastases. All you can do is listen-in.
- Forums
- ASX - By Stock
- KZA
- Alliance A071701: Genomically guided treatment trial in brain metastases.
Alliance A071701: Genomically guided treatment trial in brain metastases., page-21
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)